Harrow: The Triesence Relaunch

Group 1 - The article discusses the relaunch of Triesence, a new molecule from Harrow, following previous coverage of VEVYE and IHEEZO [1] - The Total Pharma Tracker offers tools and resources for DIY investors, including a software for extensive research material on various tickers [3] Group 2 - The data presented shows significant percentage changes over the years, indicating trends in performance from 2017 to 2023, with notable figures such as 1212% and 1200% [2][4]